Stay updated on DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab

Sign up to get notified when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.
Latest website image capture
Clouds background image

Latest updates to the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page

  1. Check
    today
    Change Detected
    Summary
    The footer revision label changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-22T14:42:41.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, with no apparent changes to the study record.
    Difference
    0.1%
    Check dated 2026-11-01T15:41:16.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and explains that the term “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    0.8%
    Check dated 2026-10-25T15:34:49.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:10:54.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T22:05:25.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry, v3.7.0, replacing the previous revision v3.6.6. This change represents an update to the page's version history rather than modifications to trial data or content.
    Difference
    0.1%
    Check dated 2026-09-20T20:59:59.000Z thumbnail image

Stay in the know with updates to DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab

Enter your email address, and we'll notify you when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.